| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.099 | 0.004 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.004 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.17 | 0.005 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.006 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.007 |